Is Adderall Safe for Seniors? ADHD Medication After 50 and After 65

The evidence on ADHD medication after 50 splits at age 65. The Adderall XR and Ritalin labels each state that the drug "has not been studied in the geriatric population," and a 2016 review of ADHD in old age stated that randomized controlled trials are lacking.^{1, 2, 3}

An Ontario cohort compared 6,457 adults aged 66 or older who started a stimulant with 24,853 who didn't. Starting a stimulant was associated with a higher risk of cardiovascular events at 30 days (hazard ratio 1.4) and no association at 365 days (hazard ratio 1.0).⁴

Ages 50 to 64 are inside the adult studies

The adult trials and cohorts reach into the 50s and early 60s. Concerta's two adult trials enrolled 627 adults aged 18 to 65, and the label indicates it for ages 6 to 65.⁵ The Vyvanse adult trial described as Study 7 enrolled 420 adults aged 18 to 55.⁶

A cohort of adults aged 25 to 64 examined heart attack, sudden cardiac death and stroke, and analyzed ages 45 to 64 as a subgroup.⁷ I've summarized its main results on the heart attack and stroke page. The Swedish long-term study covered ages 6 to 64 and stratified only at age 25.⁸ Neither reports a separate estimate for ages 50 to 64 in the sources gathered for this page in November 2026. General monitoring of blood pressure and heart rate is covered on the heart effects page.

What the labels say about age 65 and over

Source: current US prescribing information on DailyMed, geriatric use sections.^{1, 2, 6, 5}

None of the four labels lists age as a contraindication, and Concerta's limit matches the age range of its adult trials.^{1, 2, 6, 5} The Vyvanse label attributes its caution in older patients to "the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."⁶

What cohort studies found after 65

The Ontario cohort defined exposure as starting amphetamine, methylphenidate, lisdexamfetamine or dextroamphetamine between 2002 and 2015, with a median age of 74. The outcome was an emergency visit or hospitalization for heart attack, stroke or transient ischemic attack (TIA), or ventricular arrhythmia.⁴ Within a year there were 5.11 events per 100 person-years among stimulant starters and 3.66 among non-starters.⁴

• First 30 days: hazard ratio 1.4 (95% CI, 1.1 to 1.8). Ventricular arrhythmias had a hazard ratio of 3.0 (1.1 to 8.7) and stroke or TIA 1.6 (1.1 to 2.1).
• 180 days: hazard ratio 1.2 (0.9 to 1.6); ventricular arrhythmias 3.0 (1.4 to 6.4).
• 365 days: hazard ratio 1.0 (0.6 to 1.8).⁴

Death from any cause followed the same early pattern: a hazard ratio of 2.4 in the first 30 days and 0.3 at one year.⁴ That pattern could fit sicker people being started on stimulants, which could also raise the early cardiovascular figure. The abstract describes stimulant use among older adults "for a variety of indications," and the cohort was defined by the prescription, so it likely includes people treated for conditions other than ADHD.⁴

Two database studies reported much larger numbers. Among 13,233 people over 65 with ADHD, mean age 69, amphetamine exposure was associated with an odds ratio of 6.16 for cardiovascular events, with an absolute risk difference of 3.31%.⁹ The abstract gives no confidence interval or event counts. The same group reported a risk ratio of 8.9 in older adults with depression and no ADHD, even though the amphetamine group had lower systolic blood pressure and better cholesterol.¹⁰ Estimates that far from the Ontario result may reflect who is prescribed an amphetamine late in life.

Studies of older adults with ADHD

A 2016 review estimated ADHD prevalence at about 3% in older adults.³ In a separate study of older adults, the number of ADHD symptoms was positively associated with cardiovascular disease.¹¹

A review of electronic health records from a specialized adult ADHD clinic covered 113 patients aged 55 to 79. Of them, 65% reported a positive response and 42% stopped their medication because of side effects or nonresponse. Heart rate rose by a small but significant amount after methylphenidate.¹² The authors concluded that stimulants may be relatively safe and effective in older adults "under the condition that the cardiovascular parameters are monitored before and during pharmacological treatment," and called for randomized trials.¹²

The one randomized trial in people in their 70s found for this page was outside ADHD. The ADMET 2 trial assigned 200 people with Alzheimer disease and apathy, median age 76, to methylphenidate or placebo. No significant differences in the safety profile were noted, and none of the 17 serious adverse events was related to the study drug.¹³

Which ADHD medication is best for adults over 50?

No study reviewed here compares ADHD medications for effectiveness in older adults with ADHD. A Medicare study of 2,526 people aged 66 or older starting methylphenidate or amphetamine found a hazard ratio of 1.73 for methylphenidate on a combined outcome, driven by all-cause mortality (2.20); cardiovascular events alone did not differ (1.14, 95% CI, 0.77 to 1.67).¹⁴ ADHD was diagnosed in 16.3% of amphetamine starters and 8.1% of methylphenidate starters, and the authors raised the possibility of residual confounding.¹⁴ I've compared the two classes in more detail in Adderall versus Ritalin for the heart.

Limitations of the evidence

This evidence has limitations. First, the cohorts in people over 65 are observational, several include people treated for conditions other than ADHD, and they cannot establish causal relationships. Second, the cohorts follow people who newly start a stimulant, and none of the sources gathered in November 2026 reports a separate estimate for ages 50 to 64. Nevertheless, the Ontario cohort linked stimulant starts with the composite cardiovascular outcome at 30 days and not at 180 or 365 days.

For an adult over 65 considering a stimulant, the record-review authors' condition was monitoring of cardiovascular parameters before and during treatment, a plan made with the prescriber. Chest pain, fainting or shortness of breath means calling 911 or going to an emergency department.

Chest pain, fainting, or shortness of breath during treatment needs immediate medical assessment. Call 911 or go to the nearest emergency department for severe symptoms. Medication changes are made with the prescriber.

Related: Effects of ADHD medication on the heart · The long-term heart risk study · ADHD medication with high blood pressure · Heart palpitations · Children's heart safety · Heart attack and stroke · Adderall vs Ritalin · Raynaud's and cold hands · Heart rate on stimulants · Chest pain and cardiomyopathy · ADHD medication and POTS · Heart murmur and MVP · Exercise on ADHD medication